ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,300,000 | +16.1% | 751,804 | 0.0% | 2.16% | -10.8% |
| Q2 2022 | $10,593,000 | -62.2% | 751,804 | -35.0% | 2.42% | -63.4% |
| Q1 2022 | $28,018,000 | +188.0% | 1,156,817 | +177.5% | 6.62% | +106.6% |
| Q4 2021 | $9,729,000 | +40.5% | 416,817 | 0.0% | 3.21% | +27.4% |
| Q3 2021 | $6,923,000 | -33.0% | 416,817 | -1.7% | 2.52% | -40.8% |
| Q2 2021 | $10,337,000 | -7.3% | 423,817 | -2.0% | 4.25% | -9.6% |
| Q1 2021 | $11,154,000 | -53.7% | 432,317 | -4.0% | 4.70% | -45.4% |
| Q4 2020 | $24,074,000 | -9.9% | 450,317 | -30.5% | 8.61% | -23.9% |
| Q3 2020 | $26,723,000 | -5.8% | 647,833 | +10.6% | 11.32% | -10.6% |
| Q2 2020 | $28,380,000 | +11.3% | 585,517 | -3.0% | 12.66% | -18.2% |
| Q1 2020 | $25,499,000 | +15.6% | 603,517 | +17.0% | 15.46% | +15.6% |
| Q4 2019 | $22,065,000 | – | 515,788 | – | 13.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |